...
首页> 外文期刊>International journal of hematology-oncology and stem cell research. >Immunohistochemical Analysis of p53, Ki-67, CD44, HER-2eu Expression Patterns in Gastric Cancer, and Their Association with One Year Survival in North-West of Iran
【24h】

Immunohistochemical Analysis of p53, Ki-67, CD44, HER-2eu Expression Patterns in Gastric Cancer, and Their Association with One Year Survival in North-West of Iran

机译:伊朗西北部胃癌中p53,Ki-67,CD44,HER-2 / neu表达模式的免疫组织化学分析及其与一年生存率的关系

获取原文
   

获取外文期刊封面封底 >>

       

摘要

IntroductionGastric cancer remains the second most common cause of cancer-related deaths worldwide. In many malignancies like, lung and breast, multiple prognostic factors are known, such as mutations in Ki-67, HER-2eu, p53. In this study, we evaluated immunohistochemical protein expression patterns of cell-cycle-regulators p53, proliferation marker Ki-67, surface expression of CD44, HER-2eu oncogene proposed as useful prognostic factors.MethodsIn this descriptive-analytic study, we evaluate 100 patients with gastric cancer who were referred to Shahid Ghazi Hospital or other oncology clinics of Tabriz University of Medical Sciences in 2005-2010. Patients with pathologic confirmation of gastric cancer were selected. Expression of p53, ki-67, CD-44, HER-2eu were detected by immunohistochemical staining.ResultsIn this study, 100 patients with gastric cancer participated. 76(76%) were men and 24(24%) were women with mean age of 64.02(8.05) years. Seventy two samples were intestinal type and 28 were diffuse type. CD44 was positive in 27(27%) patients. P53 was positive in 35(35%) patients. Ki-67 was positive in 53(53%) patients. HER-2eu was positive in 51(51%) patients.ConclusionThe frequency of positive p53, Ki-67, CD44 and HER-2eu varied in different studies. Positive Ki-67 and HER-2eu were not associated with changes in survival but positive p53 and CD44 were significantly associated with improved survival.
机译:引言胃癌仍然是全世界与癌症相关的死亡的第二大最常见原因。在许多恶性肿瘤中,例如肺和乳腺,已知多种预后因素,例如Ki-67,HER-2 / neu,p53中的突变。在这项研究中,我们评估了细胞周期调节因子p53,增殖标志物Ki-67,CD44的表面表达,HER-2 / neu癌基因的免疫组化蛋白表达模式,这些因素被认为是有用的预后因素。 2005-2010年,将100例胃癌患者转诊至大不里士医科大学的Shahid Ghazi医院或其他肿瘤诊所。选择经病理证实为胃癌的患者。免疫组化染色检测p53,ki-67,CD-44,HER-2 / neu的表达。结果本研究纳入100例胃癌患者。平均年龄为64.02(8.05)岁的男性为76(76%),女性为24(24%)。七十二份样本为肠型,二十八份为弥散型。 27例(27%)患者中CD44阳性。 35名(35%)患者中P53阳性。 Ki-67在53(53%)位患者中呈阳性。 HER-2 / neu在51例患者中呈阳性(51%)。 Ki-67和HER-2 / neu阳性与存活率变化无关,但p53和CD44阳性与存活率改善显着相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号